MedPath

The efficacy of Double Ovarian Stimulation for enhancing oocyte yield in assisted reproductive technology in patients with poor ovarian response

Phase 2
Conditions
POOR OVERIAN RESPONSE.
Ovarian dysfunction, unspecified
E28.9
Registration Number
IRCT20200804048303N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
34
Inclusion Criteria

Poor ovarian stimulation based on Poseidon group 3 criteria, AMH less than 1.2 ng / ml, antral follicle count less than 5 and age less than 35 years Group 4 poseidon includes older age equal to 35 years and AMH less than 1.2 ng/ml and the number of antral follicles less than 5 follicles
Group 4 poseidon includes older age equal to 35 years and AMH less than 1.2 ng/ml and the number of antral follicles less than 5 follicles

Exclusion Criteria

Women with normal or excessive ovarian response
Women with excessive ovarian response

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
umber of oocytes. Timepoint: Compare the number of oocytes and MII oocytes after induction ovulation in the follicular and luteal phase and two methods flare stimulation and minimal stimulation,. Method of measurement: Ultrasonography and puncture of oocytes and evaluate the presence of a polar body.;Number of embryos. Timepoint: Number of embryos after induction ovulation and oocyte retrieval in follicular and luteal phase and compare two methods of flare stimulation and minimal stimulation. Method of measurement: Inspection of embryos under the microscope.;Number of blastocysts. Timepoint: The number of blastocysts after oocyte retrieval in the follicular and luteal phases and compare the two methods of flare stimulation and minimal stimulation. Method of measurement: Inspection of embryos under the microscope 5days after oocyte retrieval.
Secondary Outcome Measures
NameTimeMethod
Clinical pregnancy. Timepoint: 4-6 weeks after embryo transfer(ET). Method of measurement: Transvaginal ultrasonography and observe existence of gestational sac and fetal heart rate.
© Copyright 2025. All Rights Reserved by MedPath